Cargando…
Synergistic effects of low-dose chemotherapy and T cells in renal cell carcinoma
Renal cell carcinoma (RCC) is not sensitive to conventional radiotherapy and chemotherapy, and the effectiveness rate of molecular targeted therapy is low. Therefore, it is urgent to identify new treatment methods. Recently, adoptive T-cell therapy has provided a new option for cancer treatment. Fur...
Autores principales: | Xu, Dan-Dan, Ding, Men, Tong, Pan, Chong, Yan-Yun, Gu, Wei-Yu, Li, Yang, Fang, Xin-Jiang, Li, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388326/ https://www.ncbi.nlm.nih.gov/pubmed/32705278 http://dx.doi.org/10.3892/or.2020.7679 |
Ejemplares similares
-
Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies
por: Ishii, Hiroki, et al.
Publicado: (2017) -
Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation
por: Wang, Bo, et al.
Publicado: (2021) -
Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy
por: Ueno, Daiki, et al.
Publicado: (2022) -
Engineered Cell‐Derived Microparticles Bi(2)Se(3)/DOX@MPs for Imaging Guided Synergistic Photothermal/Low‐Dose Chemotherapy of Cancer
por: Wang, Dongdong, et al.
Publicado: (2019) -
Low-dose apatinib monotherapy in advanced chemotherapy-refractory
small cell lung cancer: a case series and literature review
por: Liu, Ying-ying, et al.
Publicado: (2019)